Identification of Vimentin as a Potential Therapeutic Target against HIV Infection
AbstractA combination of antiviral drugs known as antiretroviral therapy (ART) has shown effectiveness against the human immunodeficiency virus (HIV). ART has markedly decreased mortality and morbidity among HIV-infected patients, having even reduced HIV transmission. However, an important current disadvantage, resistance development, remains to be solved. Hope is focused on developing drugs against cellular targets. This strategy is expected to prevent the emergence of viral resistance. In this study, using a comparative proteomic approach in MT4 cells treated with an anti-HIV leukocyte extract, we identified vimentin, a molecule forming intermediate filaments in the cell, as a possible target against HIV infection. We demonstrated a strong reduction of an HIV-1 based lentivirus expressing the enhanced green fluorescent protein (eGFP) in vimentin knockdown cells, and a noteworthy decrease of HIV-1 capsid protein antigen (CAp24) in those cells using a multiround infectivity assay. Electron micrographs showed changes in the structure of intermediate filaments when MT4 cells were treated with an anti-HIV leukocyte extract. Changes in the structure of intermediate filaments were also observed in vimentin knockdown MT4 cells. A synthetic peptide derived from a cytoskeleton protein showed potent inhibitory activity on HIV-1 infection, and low cytotoxicity. Our data suggest that vimentin can be a suitable target to inhibit HIV-1. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 875 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Fernández-Ortega, C.; Ramírez, A.; Casillas, D.; Paneque, T.; Ubieta, R.; Dubed, M.; Navea, L.; Castellanos-Serra, L.; Duarte, C.; Falcon, V.; Reyes, O.; Garay, H.; Silva, E.; Noa, E.; Ramos, Y.; Besada, V.; Betancourt, L. Identification of Vimentin as a Potential Therapeutic Target against HIV Infection. Viruses 2016, 8, 98.
Fernández-Ortega C, Ramírez A, Casillas D, Paneque T, Ubieta R, Dubed M, Navea L, Castellanos-Serra L, Duarte C, Falcon V, Reyes O, Garay H, Silva E, Noa E, Ramos Y, Besada V, Betancourt L. Identification of Vimentin as a Potential Therapeutic Target against HIV Infection. Viruses. 2016; 8(6):98.Chicago/Turabian Style
Fernández-Ortega, Celia; Ramírez, Anna; Casillas, Dionne; Paneque, Taimi; Ubieta, Raimundo; Dubed, Marta; Navea, Leonor; Castellanos-Serra, Lila; Duarte, Carlos; Falcon, Viviana; Reyes, Osvaldo; Garay, Hilda; Silva, Eladio; Noa, Enrique; Ramos, Yassel; Besada, Vladimir; Betancourt, Lázaro. 2016. "Identification of Vimentin as a Potential Therapeutic Target against HIV Infection." Viruses 8, no. 6: 98.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.